Austin G. Duffy, Oxana V. Makarova‐Rusher, Tim F. Greten – 14 May 2016 – Biliary tract cancers (BTC) comprise a group of uncommon malignancies in which the standard therapies are minimally effective and evolve slowly. Like the majority of gastrointestinal cancers, with some notable exceptions, the impact of immune‐based approaches has yet to be seen. However, the etiological background of BTC—overlapping in almost every known causative or associated factor with inflammation—provides a strong clue that these approaches may have an impact in this group of diseases.

Y.Y. Dan – 14 May 2016

Wonhyo Seo, Hyuk Soo Eun, So Yeon Kim, Hyon‐Seung Yi, Young‐Sun Lee, Seol‐Hee Park, Mi‐Jin Jang, Eunjung Jo, Sun Chang Kim, Yong‐Mahn Han, Keun‐Gyu Park, Won‐Il Jeong – 14 May 2016 – During liver injury, hepatocytes secrete exosomes that include diverse types of self‐RNAs. Recently, self‐noncoding RNA has been recognized as an activator of Toll‐like receptor 3 (TLR3). However, the roles of hepatic exosomes and TLR3 in liver fibrosis are not yet fully understood.

Dmitry Tumin, Don Hayes, W. Kenneth Washburn, Joseph D. Tobias, Sylvester M. Black – 6 May 2016 – Liver transplantation (LT) recipients in the United States have low rates of paid employment, making some eligible for Medicaid public health insurance after transplant. We test whether recent expansions of Medicaid eligibility increased Medicaid enrollment and insurance coverage in this population.

Viju Kumar Bharathan, Biju Chandran, Unnikrishnan Gopalakrishnan, Christi Titus Varghese, Ramachandran N. Menon, Dinesh Balakrishnan, O. V. Sudheer, Puneet Dhar, Sudhindran Surendran – 6 May 2016 – The role of prostaglandin E1 (PGE1) infusion in improving early graft function has not been well defined, especially in the scenario of living donor liver transplantation (LDLT). We designed a randomized, double‐blind, placebo‐controlled trial to evaluate the role of perioperative PGE1 infusion in LDLT.

Timucin Taner, Julie Heimbach – 5 May 2016

Patricia Jones, Fasiha Kanwal – 5 May 2016

Fabrizio Panaro, Gildas Boisset, Gérald Chanques, Boris Guiu, Astrid Herrero, Hassan Bouyabrine, Georges Philippe Pageaux, Karim Boudjema, Francis Navarro – 5 May 2016 – Recipient hepatectomy is a challenging liver transplantation (LT) procedure that has life‐threatening complications. The current predictive mortality clinic‐biological scores (Child/Model for End‐Stage Liver Disease [MELD]) do not take into consideration the recipient's liver anatomy.

Michael Osseis, Chetana Lim, Chady Salloum, Georges Boustany, Alexandre Doussot, Eylon Lahat, Concepcion Gomez Gavara, Philippe Compagnon, Alain Luciani, Daniel Azoulay – 5 May 2016

Sarwa Darwish Murad, Jeff L. Fidler, John J. Poterucha, William Sanchez, Sheila G. Jowsey, David Nagorney, Charles B. Rosen, Julie K. Heimbach – 4 May 2016 – Although short‐term risks of living donor hepatectomy have been well defined, little is known about the longterm impact. We aimed to perform a systematic follow‐up to screen for unanticipated health consequences of liver donation.